Pioneering Healthcare Innovation & Global Expansion with Safe Entry Stations
Revolutionizes Health Screening with 95% Accuracy
Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
The spotlight on Predictmedix AI in the Toronto Star underscores the company's commitment to cutting-edge technology and innovation in the healthcare sector. With the rapid advancements in AI and healthcare, Predictmedix continues to set industry standards by introducing ground-breaking solutions that has the potential to revolutionize patient care at scale.
14 Jan 2021: Demonstration of PredictMedix's Safe Entry Station (video)
Dr. Kushwah, COO & Co-Founder of PredictMedix, demonstrates the Safe Entry Station for Infectious Diseases and Cannabis & Alcohol Impairment. For more information, get in touch with the team at predictmedix.com.
4 Jun 2020: COVID-19 Solutions for your Business (video)
28 May 2020: CityTV news interviews Predictmedix's Dr. Rahul Kushwah (video)
CityTV news interviews Dr. Rahul Kushwah about Predictmedix's technology for COVID-19 mass screening technology.
Wellness 4 Humanity Partners set to deploy and offer Safe Entry Stations at Simon Mall’s Houston Galleria
TORONTO, Dec. 02, 2020 (GLOBE NEWSWIRE) — Led by a team of social entrepreneurs, Clinicians, and wellness gurus, Wellness 4 Humanity was one of the first on the scene to offer disruptive Covid-19 testing to support communities and organizations throughout the pandemic.
Predictmedix and Paras Defence & Space Technologies Are Joining Forces
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company is partnering with Paras Defence & Space Technologies Ltd. (“Paras”), which is India’s most progressive Tier 2 Defence Engineering Company to target the government and the public sector market in South Asia.
PredictMedix Is Partnering With McGill Researchers for Clinical Research
TORONTO, ON / ACCESSWIRE / November 10, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company is partnering with the research group led by Dr. Samira Rahimi for clinical research.
PredictMedix Provides Corporate Update
TORONTO, ON / ACCESSWIRE / October 27, 2020 / PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities in relation to its infectious disease screening technology and its remote patient monitoring platform, Mobile Wellbeing.
Accenture: Health innovation: A cure for COVID-19 disruptions
A select group of health systems and hospitals are differentiating themselves from their peers, investing in the innovations they need to navigate the long-term uncertainties imposed by COVID-19.